Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Uniqure is a biotech that has developed a promising treatment for Huntington's disease, a relatively rare, 100% fatal neurodegenerative disease. It published results...
— Hawkins Entrekin
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on uniQure N.V.
V. is a clinical-stage...
V. is developing AMT-130,...
More institutional theses from Warden Capital
CoreWeave Inc. ($CRWV) is referenced as a distressed neocloud bellwether whose debt yields have surged to 14-15%, signaling broader financing stress across AI infrastructure.
Intuit Inc. develops mission-critical business accounting software (QuickBooks) and tax preparation solutions (TurboTax). The manager has...
D-Wave Quantum Inc. is a hardware developer specializing in quantum annealing systems and specialized optimization computing. The manager holds...